Previous close | 2,742.50 |
Open | 0.00 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 0.00 - 0.00 |
52-week range | |
Volume | |
Avg. volume | 4,135,328 |
Market cap | 60.672B |
Beta (5Y monthly) | 0.32 |
PE ratio (TTM) | 18.19 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 0.81 (2.96%) |
Ex-dividend date | 29 Feb 2024 |
1y target est | N/A |
Clorox's (CLX) third-quarter fiscal 2024 bottom line benefits from pricing actions and cost-saving initiatives. The company also boasts a solid innovation pipeline.
Archer Daniels (ADM) reports lower revenues year over year in first-quarter 2024 due to a decline in sales across all segments.
FEMSA (FMX) posts lower earnings year over year in first-quarter 2024. However, revenues improved 11.3% year over year.